- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07604012
Holistic Lifestyle mHealth Intervention for Risk Reduction of Type 2 Diabetes Mellitus in Young Adults
Effectiveness of Holistic Lifestyle mHealth Intervention for Risk Reduction of Type 2 Diabetes Mellitus in Young Adults: A Randomized Controlled Trial
The goal of this clinical trial (randomized controlled trial) is to examine the effectiveness of a holistic lifestyle mHealth intervention in reducing the risk of type 2 diabetes mellitus.
The study focuses on young adults aged 20-35 years, recruited from public and private universities in Rawalpindi and Islamabad, who meet the defined inclusion criteria.
The main questions it aims to answer are:
Does a holistic lifestyle mHealth intervention significantly reduce the risk of type 2 diabetes ? Does the intervention improve overall health-related quality of life and lifestyle behaviors, including diet, physical activity, and stress management?
Study Overview
Status
Intervention / Treatment
Detailed Description
Researchers will compare participants receiving the holistic lifestyle mHealth intervention (based on "Eat Well, Move More, Stress Less") with a control group receiving standard care or basic health guidance to see if the intervention leads to greater reduction in diabetes risk and improved health outcomes.
Participants will:
Use a culturally tailored mHealth application designed for the Pakistani context Follow lifestyle recommendations focused on diet, physical activity, and stress management Engage with intervention content based on the three core pillars: Eat Well, Move More, Stress Less Participate in periodic assessments, including health measurements and questionnaires Provide feedback on their experience and adherence to the intervention
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Anmol Ayaz, Phd Scholar
- Phone Number: 923335791127
- Email: anmol.ayaz@fjwu.edu.pk
Study Contact Backup
- Name: Sajida Naz Dr
- Phone Number: +92 323 5493535
- Email: dr.sajida@fjwu.edu.pk
Study Locations
-
-
Punjab Province
-
Rawalpindi, Punjab Province, Pakistan, 46000
- University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Young adults aged between 20-35 years, as defined by the WHO.
- At risk of diabetes based on self-reported family history or lifestyle habits.
- Participants who are willing to engage in the mHealth intervention program.
- Own a smartphone and are familiar with using mobile apps.
- Complete the informed consent process, agreeing to follow the study protocol, including survey completion and health assessment.
Exclusion Criteria:
- Individuals diagnosed with chronic mental or physical illnesses
- Individuals with hearing or vision loss so severe that they could not access the mobile health intervention.
- Pregnant women or women who plan on becoming pregnant during the study.
- Individuals who are already taking part in an equivalent diabetes or health programme.
- Individuals who are not willing to provide consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Group
|
The main components of the holistic mHealth intervention include the following: nutritional education, promotion of physical activity, sleep education, and behavioral health support.
The integration of these components in mHealth promotes a holistic lifestyle through enhancing overall health-related quality of life.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Improved quality of Life
Time Frame: 6-8 weeks
|
Measured using a validated tool, the Short Form Health Survey (SF-36), assessed at baseline and post-intervention. The primary endpoint is the difference in mean risk scores between the intervention and control groups. score ≤ 44 indicates weak, 45-63 indicate medium, ≥ 64 indicate good. |
6-8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Secondary outcome measures include changes in blood glucose level
Time Frame: 8 weeks
|
Diabetes risk assessment is assessed through RAPID (Risk Assessment of Pakistani Individual for Diabetes) . Changes in blood glucose levels assessd through HbA1c measured in mg/dL at baseline and post-intervention. |
8 weeks
|
|
Food literacy
Time Frame: 8 weeks
|
Food literacy measured by using Self-Perceived Food Literacy Scale Short Form Scoing : <30.6 indicates inadequate-limited food literacy; >31 indicates adequate-excellent food literacy.
|
8 weeks
|
|
Eating Behavior
Time Frame: 8 weeks
|
Eating Behavior measured by using Self-Regulation of Eating Behavior Questionnaire for Adults.
Scoring: <2.8 indicate Low level, 2.8 to 3.6 indicate Medium>3.6High
|
8 weeks
|
|
Physical Health
Time Frame: 8 weeks
|
weight will be combined to report BMI in kg/m^2.
|
8 weeks
|
|
sleep quality
Time Frame: 8 weeks
|
Sleep Quality measured by Pittsburgh Sleep Quality Index (PSQI) Scoring :0 - No sleep difficulties; 5 or higher - Poor sleep quality |
8 weeks
|
|
Psychological Distress
Time Frame: 8 weeks
|
Psychological Distress will be measured by using Depression, Anxiety and Stress Scale (DASS-21) Scoring: Depression : 0-9 normal ,14-20 moderate , 28+ severe Anxiety : 8-9 mild , 10-14 moderate Stress: 15-18 mild, 19-25 moderate |
8 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- JinnahUW
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
De-dentified participant data underlying the published results may be made available upon reasonable request. Shared data may include demographic variables, outcome measures, and analyzable datasets relevant to the study objectives.
Data requests may be submitted to the principal investigator. Access will be considered for researchers with methodologically sound proposals and subject to institutional ethical approval and data use agreements.
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes Risk Reduction in Young Adults
-
Western University, CanadaCompletedType2 Diabetes | Lifestyle Risk ReductionCanada
-
Western University, CanadaNot yet recruitingType 2 Diabetes | Cognitive Decline in Older AdultsCanada
-
Seoul National University HospitalInje University; Kangbuk Samsung HospitalRecruitingDiabetes Mellitus, Type 2 | Lifestyle Risk ReductionKorea, Republic of
-
Gia MuddNational Institute of Nursing Research (NINR); National Institutes of Health...CompletedCardiovascular Diseases | Diabetes Mellitus, Type 2 | Risk Reduction BehaviorUnited States
-
Gia MuddNational Institute of Nursing Research (NINR)CompletedCardiovascular Diseases | Diabetes Mellitus, Type 2United States
-
University of WashingtonGlaxoSmithKline; Seattle Institute for Biomedical and Clinical ResearchCompleted
-
Wake Forest University Health SciencesAlliance for Research and Innovations in Pediatric Oncology (ARISE) Cancer...Not yet recruitingOsteosarcoma in Children | Osteosarcoma in Adolescents and Young AdultsUnited States
-
Steno Diabetes Center CopenhagenUniversity of CopenhagenCompletedType 2 Diabetes | Maturity-Onset Diabetes of the Young, Type 3Denmark
-
Imperial College LondonUnknownDiabetes | Type 1 Diabetes | Type 2 Diabetes | Maturity Onset Diabetes of the YoungUnited Kingdom
-
Taichung Veterans General HospitalNational Health Research Institutes, TaiwanRecruitingDiabetes Complications | Type 2 Diabetes | Maturity-Onset Diabetes of the Young (MODY)Taiwan
Clinical Trials on Holistic mHealth Intervention
-
The University of Texas Health Science Center at...Completed
-
George Mason UniversityCompletedPeripheral NeuropathyUnited States
-
University GhentLiantisRecruiting
-
University of CadizAndalusian Health ServiceRecruiting
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI); Ohio UniversityRecruitingMelanoma | Breast Cancer | Multiple Myeloma | Lung Cancer | Prostate CancerUnited States
-
Children's National Research InstituteRecruitingSexually Transmitted DiseasesUnited States
-
Kaiser PermanenteCompletedSmoking | Smoking CessationUnited States
-
KU LeuvenJomo Kenyatta University of Agriculture and TechnologyCompleted
-
University of FloridaCompleted
-
The Hong Kong Polytechnic UniversityThe University of Hong Kong; Kwong Wah Hospital; University of Glasgow; Tsan Yuk...RecruitingQuality of Life | Family Relations | Postnatal DepressionHong Kong